Protocol HKT-500-US10: A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of HKT-500 in the Treatment of Pain Associated With Grade I or Grade II Ankle Sprain
Phase of Trial: Phase III
Latest Information Update: 16 Jun 2015
At a glance
- Drugs Ketoprofen (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 27 Apr 2010 Results have been announced, according to a Hisamitsu Pharmaceutical Co media release.
- 09 Jun 2008 New trial record.